The FDA’s Overton era, and dispatches from Shanghai

The item is an episode announcement for STAT's weekly biotech podcast 'The Readout LOUD,' which is going international this week. STAT's Jason Mast joins from Shanghai, where he is digging into what the rise of Chinese drug development means for the biotech industry. The episode also has colleague Margaret Manto speaking about Heidi Overton, the president's pick to be commissioner of the Food and Drug Administration, and asks whether the new nominee will bring needed stability or controversy to the troubled agency.

The excerpt profiles the podcast's regular contributors. Elaine's coverage includes the boom in new obesity treatments, new drug payment models, how companies are affected by FDA changes, and the emerging psychedelics drug sector; she co-writes The Readout newsletter and co-hosts The Readout LOUD. Adam Feuerstein is a senior writer and biotech columnist covering drug development, business, Wall Street, and biotechnology; he co-hosts the weekly biotech podcast and authors the newsletter Adam's Biotech Scorecard. Allison covers hot startups and who is financing them, and also co-hosts the weekly biotech podcast. Signal contacts are provided: Elaine at elaineywchen.70, Adam at stataf.54, and Allison at AllisonDeAngelis.01.

The item directs readers to more on Overton and her views on China, coverage of the ITM and Telix merger, and the latest news on osteoporosis. It also encourages listeners to sign up for 'The Readout LOUD' on Apple Podcasts, Spotify, or wherever podcasts are available.